A Composition For Treating Inflammation

Itc Limited
Reply Not Filed App No 201741020845 Biotechnology

Patent information

IP India · live record
Application number
201741020845
Filing date
14 June 2017
Status
Reply Not Filed
Publication number
51/2018
Publication type
INA
Invention field
Biotechnology

Abstract

The present disclosure relates to a composition comprising green tea extract and a compound selected from the group consisting of rutin, rutin hydrate, rutin trihydrate, and combinations thereof which at specific w/w ratios is able to curb the effects of inflammation. Also provided are the methods of preparation and usage of the same.

Applicants

1
India
ITC LIMITED ITC-LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bengaluru 560 058, India

Inventors

2
India
NARAYANAPERUMAL, JeyaparthasarathyITC-LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bengaluru 560 058, India
India
GOPAL, GaneshITC-LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bengaluru 560 058, India

Claims

11
1 A synergistic composition comprising: a) green tea extract; and b) a compound selected from the group consisting of rutin, rutin hydrate, rutin trihydrate, and combinations thereof, wherein the green tea extract to the compound w/w ratio in said composition is in the range of 1:0.125–1:5.
2 The composition as claimed in claim 1, wherein the green tea extract to rutin trihydrate w/w ratio in said composition is in the range of 1:0.5–1:2.
3 The composition as claimed in claim 1, wherein the green tea extract to rutin trihydrate w/w ratio in said composition is 1:0.5.
4 The composition as claimed in claim 1, wherein the green tea extract to rutin trihydrate w/w ratio in said composition is 1:0.75.
5 The composition as claimed in claim 1, wherein the green tea extract to rutin trihydrate w/w ratio in said composition is 1:2.
6 The composition as claimed in any of the claims 1-5, further comprising: a) at least one carrier; b) at least one diluent; and c) at least one excipient.
7 A method for preparing a composition as claimed in claim 1, comprising: a) obtaining green tea extract; b) obtaining rutin trihydrate; and c) contacting the green tea extract and rutin trihydrate thereof to obtain said composition.
8 A method for preparing a composition as claimed in any of the claims 1-6, comprising: a) obtaining green tea extract; b) obtaining rutin trihydrate; c) obtaining at least one carrier; d) obtaining at least one diluent; e) obtaining at least one excipient; and f) contacting the green tea extract, rutin trihydrate, the at least one carrier, the at least one diluent, and the at least one excipient to obtain said composition.
9 The composition as claimed in any of the claims 1-6, wherein said composition inhibits inflammatory response by inhibiting activated - NF-?B protein.
10 The composition as claimed in any of the claims 1-6, wherein said composition inhibits inflammatory response by inhibiting monocyte chemotactic activity.
11 The composition as claimed in any of the claims 1-6, wherein said composition is used for preparing formulations for anti-inflammatory products. , Description:AS ATTACHED

Specification

Show full textCollapse

Claims:1. A synergistic composition comprising: a) green tea extract; and b) a compound selected from the group consisting of rutin, rutin hydrate, rutin trihydrate, and combinations thereof, wherein the green tea extract to the compound w/w ratio in said composition is in the range of 1:0.125–1:5. 2. The composition as claimed in claim 1, wherein the green tea extract to rutin trihydrate w/w ratio in said composition is in the range of 1:0.5–1:2.

3. The composition as claimed in claim 1, wherein the green tea extract to rutin trihydrate w/w ratio in said composition is 1:0.5.

4. The composition as claimed in claim 1, wherein the green tea extract to rutin trihydrate w/w ratio in said composition is 1:0.75.

5. The composition as claimed in claim 1, wherein the green tea extract to rutin trihydrate w/w ratio in said composition is 1:2.

6. The composition as claimed in any of the claims 1-5, further comprising: a) at least one carrier; b) at least one diluent; and c) at least one excipient.

7. A method for preparing a composition as claimed in claim 1, comprising: a) obtaining green tea extract; b) obtaining rutin trihydrate; and c) contacting the green tea extract and rutin trihydrate thereof to obtain said composition.

8. A method for preparing a composition as claimed in any of the claims 1-6, comprising: a) obtaining green tea extract; b) obtaining rutin trihydrate; c) obtaining at least one carrier; d) obtaining at least one diluent; e) obtaining at least one excipient; and f) contacting the green tea extract, rutin trihydrate, the at least one carrier, the at least one diluent, and the at least one excipient to obtain said composition.

9. The composition as claimed in any of the claims 1-6, wherein said composition inhibits inflammatory response by inhibiting activated - NF-?B protein.

10. The composition as claimed in any of the claims 1-6, wherein said composition inhibits inflammatory response by inhibiting monocyte chemotactic activity.

11. The composition as claimed in any of the claims 1-6, wherein said composition is used for preparing formulations for anti-inflammatory products. , Description:AS ATTACHED

Documents

Sign in to open
Application documents
1 Form 5 [14-06-2017(online)].pdf 14 Jun 2017
2 Form 3 [14-06-2017(online)].pdf 14 Jun 2017
3 Drawing [14-06-2017(online)].pdf 14 Jun 2017
4 Description(Complete) [14-06-2017(online)].pdf_40.pdf 14 Jun 2017
5 Description(Complete) [14-06-2017(online)].pdf 14 Jun 2017
6 201741020845-Proof of Right (MANDATORY) [22-08-2017(online)].pdf 22 Aug 2017
7 201741020845-FORM-26 [22-08-2017(online)].pdf 22 Aug 2017
8 Correspondence by Agent_Power of Attorney_24-08-2017.pdf 24 Aug 2017
9 IMPORTANT LETTER FROM NBA.pdf 03 Apr 2019
10 201741020845-FORM 18 [25-03-2021(online)].pdf 25 Mar 2021
11 201741020845-FER.pdf 23 Jul 2025
12 201741020845-FORM 3 [17-09-2025(online)].pdf 17 Sep 2025
Search strategy
1201741020845_SearchStrategyNew_E_SearchStrategyE_17-07-2025.pdf